Connection

Nirav Shah to Leukemia, B-Cell

This is a "connection" page, showing publications Nirav Shah has written about Leukemia, B-Cell.
Connection Strength

0.701
  1. Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial. Nat Med. 2020 10; 26(10):1569-1575.
    View in: PubMed
    Score: 0.701
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.